A possible role for chromium(III) in genotoxicity. by Snow, E T
Environmental Health Perspectives
Vol. 92, pp. 75-81, 1991
A Possible Role for Chromium(lll) in
Genotoxicity
by Elizabeth T. Snow*
Chromium is found in the environment in two majorforms: reduced Cil' andCrVy, orchromate.
Chromate, the most biologically active species, is readily taken up by living cells and reduced
intracellularly, via reactive intermediates, to stable Cr"I species. Cr'l, the most abundant form of
chromium in the environment, does not readily cross cell membranes and is relatively inactive
in vivo. However, intracellular Crl" canreact slowly with both nucleic acids and proteins and can
be genotoxic. We have investigated the genotoxicity ofCr"P in vitro using a DNAreplication assay
and in vivo byCaCl2-mediated transfection ofchromium-treated DNAintoEscherichia coli. When
DNA replication was measured on a Cr"'-treated template using purified DNA polymerases
(either bacterial or mammalian), both the rate ofDNA replication and the amount ofincorpora-
tion per polymerase binding event (processivity) were greatly increased relative to controls.
Whentransfected intoE. coli, Cr"l-treated M13mp2bacteriophage DNA showed a dose-dependent
increase in mutation frequency. These results suggest that Cr"' alters the interaction between
the DNA template and the polymerase such that the binding strength ofthe DNA polymerase is
increased and the fidelity ofDNA replication is decreased. These interactions may contribute to
the mutagenicity of chromium ions in vivo and suggest that Cr"' can contribute to chromium-
mediated carcinogenesis.
Introduction
Chromate is a well-documented human and animal
carcinogen. Occupational and environmental exposure
to chromium has been widespread, and many studies of
the biological effects of chromate compounds have been
conducted (1-3). However, because ofits complex intra-
cellular metabolism, molecular mechanisms ofchromium-
induced genotoxicity are not well understood. Chromium
genotoxicity and carcinogenesis are complex processes.
Chromate ions are actively transported across cell
membranes and are reduced intracellularly via reactive
Crv and CrIv intermediates to stable Cr"' species. Dur-
ing this process, oxidative DNA damage and chromium-
mediated crosslinks are produced, and point mutations
are induced in a number oftarget genes. However, the
mechanisms of chromium-induced mutagenesis are still
unclear.
Numerous studies have attempted to determine which
intracellular form of chromium or byproduct of chro-
mium reduction is the ultimate carcinogenic and/or mu-
tagenic species (3-5). Redox interactions resulting from
chromium reduction (including oxidative base damage)
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are generally considered the most likely cause of chro-
mate mutagenesis. These processes have been impli-
cated, in part, by increased chromate mutagenesis in A/
T-specific Salmonella reversion strains (e.g., TA102)
compared with that in G/C specific strains (TA100) (6);
by the formation of 8-hydroxyguanine in chromium-
treated DNA in vitro (7); and by the formation ofactive
Crv species in vitro (3). Crl" is also of interest because
it can react with intracellular electrophiles, including
nucleic acids, and is the most stable and plentiful form
of chromium both in the environment and within the
cell after chromate uptake and reduction. As much as
90% ofthe cellular chromium is present as the trivalent
species (8). But Cr"' does not readily cross cell mem-
branes and is relatively inactive in vivo and in cells in
culture (9).
Experiments that have attempted to determine the
carcinogenic and mutagenic potential ofCr"' compounds
in vivo yielded negative or ambiguous results (2). Nev-
ertheless, Criii compounds can reach the nucleus ofcells
within target organs (10) and, once inside the cell, Crii"
species can be mutagenic (11-13) and genotoxic (13).
Recent evidence suggests that CrIII species, although
previously considered "kinetically inert," can readily
bind to nucleic acids in vitro and can even act as redox
agents when complexed to a conjugated aromatic ligand
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increase in misincorporation by DNA polymerases dur-
ing DNA replication in vitro (15,16). In addition, Cr"'
ions bound to nuclear DNA increased RNA synthesis
in vitro by increasing nonspecific initiation (17-19). This
suggests that Cr"' might influence the regulation ofgene
transcription (17).
We have investigated the mechanisms of Cr"'
genotoxicity in vitro using a DNA replication assay and
in vivo by transfection of CrI"'-treated DNA into com-
petent E. coli for scoring of survival and mutagenesis.
Single-stranded M13 DNA was treated with low con-
centrations ofCrCl3 and excess chromium was removed
by gel filtration. DNA replication was then measured
on the treated templates. Both the rate ofDNA replica-
tion and the amount of incorporation per polymerase
binding event (processivity) were greatly increased on
the chromium-treated template. This process is not
polymerase dependent and has been seen with such
diverse enzymes as E. coli DNA polymerase I and
eukaryotic DNA polymerases a (20) and P3. At an opti-
mum concentration of 1 Cr"' ion bound per 300 nucle-
otides, the rate ofsynthesis by E. coli DNA polymerase
I (Klenow) was increased 6-fold relative to the control.
When transfected into E. coli, CrI"'-treated M13mp2
bacteriophage DNA showed a dose-dependent increase
in mutation frequency up to 5-fold above background.
These results suggest that Cr"' alters the structure of
the DNA template resulting in both an increase in the
binding strength ofthe DNA polymerase and a decrease
in the fidelity of DNA replication. The combined effect
ofthis template-polymerase association may be the un-
faithful bypass of DNA lesions. The CrI"'-DNA interac-
tions may thus contribute to both the mutagenicity of
chromium ions in vivo and to chromium-mediated
carcinogenesis by synergistically enhancing the muta-
genicity ofany DNA lesions produced during the intra-
cellular reduction ofCrVl in vivo.
Experimental Procedures
Materials
M13mp2 and M13mp7 single-stranded bacteriophage
DNA was prepared using standard procedures (21).
Unlabeled deoxynucleotides were obtained from Sigma
Chemical Co. (St. Louis, MO); 32P-labeled nucleotides and
51CrCl3 (20.5 mCi/mmole) were from New England
Nuclear (Boston, MA). The M13 17-mer sequencing
primers were synthesized by Bernard Goldschmidt,
Department of Environmental Medicine, New York
University Medical Center. The T7 Sequenase kit was
obtained from the United States Biochemical Corpora-
tion (Cleveland, OH). Polymerase I-Klenow fragment
(pol I-KF) was obtained from Boehringer Mannheim
(Indianapolis, IN). Cloned human DNA polymerase ,B
(22) was a kind gift from Samuel Wilson ofthe National
Cancer Institute. Escherichia coli JM101 was cultured
from laboratory stocks maintained on minimal agar
plates. Bacto-tryptone, agar, and yeast extract were
obtained from Difco laboratories (Detroit, MI). All other
chemicals were ofmolecularbiology or DNA grade, and
all water was purified through a Milli-Q purification
system. All CrCl3 solutions were made fresh daily and
diluted as required immediately before use.
Measurement ofCr"' Bound to
M13mp2 DNA
M13mp2 single-stranded DNA was treated with
5'CrCl3 (0.4-50 ,uM) at 37°C for 30 min in a 50-pL
reaction mixture containing 2 pg ofDNA, 0.2 mM Tris-
HCl (pH 8.0), and 20 ,uM EDTA. After incubation, the
reaction mixtures were spun through Sephadex G-50
spin columns, prepared as described in Maniatis et al.
(21), to remove the unbound 51CrIII ions. The amount of
5'Cr remaining bound to the DNA was determined by
counting the samples in a NaI(T1) scintillation detector
coupled to amultichannel analyzer. 3H-TdR-labeled DNA
was used in a control reaction to measure DNA recovery.
DNA Replication Using Cr-Treated
M13mp2 Primer-Templates
M13 17-mer sequencingprimerwas 5' end-labeled with
y-32P-ATP (3000 Ci/mmole) and T4 polynucleotide kinase
(21). M13mp2 single-stranded DNA was hybridized with
a 2-fold molar excess of either radiolabeled or cold
primer in a 100-pL reaction mixture containing 20 mM
Tris-HCl (pH 7.4), 10 mM MgCl2, 50 mM NaCl, and 10
mM dithiothreitol at 55°C for 10 min, then slowly cooled
to room temperature. Chromium-treated templates were
prepared by first reacting the DNA template with CrCl3
for 30 min at 37°C and removing the excess chromium
by gel filtration, as above. The treated DNA was then
hybridized with 2-fold excess primer. Replication was
carried out at 370C for 15 min using 0.2 pg ofthe modi-
fied DNA template and 0.04 units of pol I-KF in a
20-,L reaction mixture containing 40 mM Tris-HCl (pH
7.4), 10 mM ,-mercaptoethanol, 5 mM MgCl2, and 50 ,uM
each dNTP (deoxyadenosinetriphosphate, deoxycytidine
triphosphate, deoxguanosine triphosphate, deoxythy-
midine triphosphate). The reaction was stopped by the
addition ofEDTA to a final concentration of 10 mM and
the amount of nucleotide incorporation was calculated
from the 10% (w/v) trichloroacetic acid-precipitable
counts collected on GF/C filters. Each determination
was performed in triplicate and the results are pre-
sented as the average (± standard error).
Primer Extension Assays
Primer extension was carried out as above using
M13mp7 DNA with a 5' end-labeled primer and 0.2 units
of cloned DNA polymerase f3 in the presence of 0, 1, 5,
or 10 ,uM CrCl3. (One unit ofpolymerase aequals 1 nmole
deoxynucleotide monophosphate incorporated into acti-
vated calfthymus DNA in 30 min at 370C.) The primed
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DNA was mixed first with the CrCl3 solution, the ex-
tension reactions were initiated by the addition of
deoxynucleotide triphosphates and 5 mM MgCl2, incu-
bated at 37°C for 15 min, and stopped by the addition of
0.5 M EDTA to yield a final concentration of 10 mM.
Aliquots were transferred to 1.5-mL microtubes and
mixed with loading buffer (99% deionized formamide,
10 mM Na2EDTA, 10 mM NaOH, and 0.3% each xylene
cyanol FF and bromphenol blue) then heated to 960C
for 3 to 4 min and rapidly chilled on ice before loading
on an 8% (w/v) polyacrylamide-5 M urea gel which had
been prerun for 15 to 30 min. Gel electrophoresis was
carried out at 1600 to 1800 V until the dye front was
within 2 in. ofthe bottom. The gel was then transferred
to 3M Whatman filter paper and dried for 30 min at
700C. The dried gel was placed with X-ray film (Kodak
XAR-2) and exposed for 1 to 7 days at -700C with an
intensifying screen. Sequencing reactions were carried
out using 5' end-labeled primers and templates, pre-
pared as described above, and the "Sequenase" enzyme
and buffers according to the manufacturer's instruction
with the following modifications: 0.25 ,M dATP was
added to each ofthe termination buffers and the label-
ing mix was diluted 10-fold to increase production of
short sequences.
Mutagenesis Assay
M13mp2 single-stranded DNA template (0.2 gg)
primed with 15-mer was reacted with 0 to 10 iM CrCl3
for 30 min at 370C in a total volume of 50 ,uL in 50 mM
Tris-HCl buffer (pH 7.4). The samples were then filtered
through Sphadex G-50 spin columns (1000 rpm, 5 min)
to remove free CrCl3. The metal-treated DNA (1-20 ng/
sample) was used to transfect 0.2 mL ofcalcium-treated
E. coli JM101 competent cells which were prepared us-
ing standard procedures (21). The average transfection
efficiency of untreated, single-stranded M13mp2 DNA
in JM101 was about 400 plaques per nanogram DNA.
Aliquots oftransfected cells (approximately 10,L) were
plated individually to give approximately 200 to 500
plaques/plate, as described previously (20). The plates
were incubated overnight at 370C, then nonmutant (dark
blue) and colorless or light blue (mutant) plaques were
counted after 16 to 24 hr at room temperature.
Results and Discussion
Both Cr"' and Crvy have been surprisingly refractory
in producing mutagenic DNA damage in vitro (16,23).
Although it is known that chromium produces significant
DNA damage and mutagenesis in vivo, it is not clear
what species ofchromium ions produce mutagenic DNA
damage or what specific type of mutagenic damage is
produced by chromium. It has been postulated, for ex-
ample, that Crv intermediates facilitate the production
of oxidative damage within the cell and that Crv-
glutathione conjugates may be involved in DNA-protein
crosslinking [see Connett and Wetterhahn (24) for re-
view]. Cr"', on the other hand, has been implicated as a
DNA-DNA and DNA-protein crosslinking agent (25,26)
but may also be mutagenic directly or by indirect inter-
ference with DNA replication fidelity and bypass of
DNA lesions. Many different experimental approaches
have been used to determine the mutagenic mechanism
of Cr"' compounds. However, due to the poor ability of
Cr"' ions to cross the cell membrane in vivo, these
studies have generally proven negative. In contrast,
DNA replication in vitro using synthetic polynucleo-
tides and/or OX174 DNA templates in the presence of
CrCl3 or CrCl2 (which rapidly becomes Cr"' in aqueous
solution) shows a chromium-dependent increase in the
frequency of nucleotide misincorporation (15,16,23).
Experiments by Tkeshelashvili et al. (16), for example,
have shown that in vitro incubation ofOX174am3 DNA
with CrO3 produces a 2-fold increase in reversion fre-
quency.
In our preliminary experiments (20), the effects of
CrCl3 on DNA replication in vitro were examined in the
presence of both template-bound Cr"' and free Cr"'
ions. Under these conditions, low concentrations ofCr"'
increased, then decreased, DNApolymerase activity and
also promoted increased polymerase processivity (20). In
subsequent experiments the inhibition of DNA replica-
tion by free Cr"' ions (21,29) was eliminated by removal
ofunbound Cr"' ions before DNA replication was begun.
Chromium binding to DNA is a relatively slow process
(data not shown), and a preincubation time of 30 min
was chosen for convenience. Cr"' binding to DNA under
these conditions is dose dependent, as shown in Figure
1. This binding is primarily electrostatic in nature, since
40% or more the bound ions can be displaced by a 15-
min high salt wash (0.5 M NaCl) at 370C, and only 10 to
20% of the chromium is chelatable by 20 mM EDTA (a
kinetically slow process) under the same conditions (re-
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FIGURE 1. Cr"' binding to DNA in vitro. Atotal of2 ,ugsingle-stranded
M13mp2 DNA per reaction was incubated with 5ICrCl, in a total
volumeof50,uLTE/50(0.2mMTris-HCl,pH8, 20,MEDTA)at37°C
for 30 min. Nonbound chromium was then removed by gel filtration
through a 1-mL Sephadex G-50 spin column at room temperature.
The amount of chromium remaining bound to the DNA template
afterG-50chromatography(S)was determinedbyusinga NaI scin-
tillation counter. DNA recovery determined in a separate experi-
ment using3H-labeled M13 DNA was found to average 85± 3%.
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FIGURE2. Nucleotideincorporation onachromium-bound templateand
binding ofCrCl3 to single-stranded M13mp2 DNA. Single-stranded
M13 DNA was treated for30 min at 37°C with 0 to 50 ,uM CrCl3 in a
total volume of50 ,uL, and the unbound chromium was removed by
gel exclusion chromatography, as described in the legend to Figure
1. DNA replication was then carried out on 0.2 gg of treated tem-
plate, andthetrichloroacetic acid precipitable nucleotideincorpora-
tion was measured (0).
sults not shown). It is probable that this initial binding
ofrelatively low concentrations ofCrCl3 is to the phos-
phate backbone ofthe DNA (see discussion below).
Both nucleotide incorporation and primer extension
were then examined using the chromium-treated tem-
plate. Figure 2 shows the results ofnucleotide incorpo-
ration in which DNA templates pretreated with as little
as 0.4 ,uM CrCl3 exhibited 2-fold increased nucleotide
incorporation, while pretreatment with 2 ,uM CrCl3
produced a 6.3-fold increase in nucleotide incorporation.
The amount of Cr"' bound to the template under the
conditions used for these experiments was determined
by measuring the amount of radioactive 5'Cr bound to
the DNA after gel filtration through Sephadex G-50
(Fig. 1). As shown here, the rate ofnucleotide incorpo-
ration is greatest on a template treated with 2 ,uM CrCl3.
At this concentration the treated template contains
approximately 1 bound Cr"' ion per 300 nucleotides (25
Cr"' ions/template). However, even DNA templates
treated with 50 jM CrCl3 which contain as many as one
chromium ion bound for every six nucleotides, still show
over a 4-fold increase in nucleotide incorporation relative
to the untreated control.
We also studied nucleotide incorporation by primer-
extension analysis using a 5'-32P-labeled oligonucleotide-
primed M13mp2 template to determine the length of
the extended primers on sequencing gels, as shown in
Figure 3. This assay allows us to investigate sequence-
specific polymerase pausing and termination with the
same template and primer used in the incorporation
assays. Ourprevious results suggested that polymerase
processivity can be increased by low concentrations of
chromium and that either DNA-DNA or DNA-protein
crosslinking may also be increased at doses of 5 to 10
jM Cr"' (20). These results were further confirmed by
sequencing gel analysis of replication on chromium-
treated templates in the absence offree chromium. Af-
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FIGURE 3. Crl" increases primer extension by cloned eukaryotic DNA
polymerase I on a single-stranded template. M13mp7 was primed
witha5'end-labeledsequencingprimer,asdescribedin"Experimen-
tal Procedures" and replicated with DNA polymerase Iin the pres-
enceofCrCl3at37°Cfor15min.Theproductswereanalyzedonan8%
sequencinggeladjacent toddTTPand ddGTP sequencingreactions
preparedusingtheT7Sequenasekitwiththesametemplateandend-
labeled primer in the absence ofchromium.
ter treatment ofthe template with 1 to 5 ,uM CrC13, the
extended primers are much longer than those seen in
the absence of chromium, and the increased length is
dose dependent. These results suggest that it is the
Cr"' ions that are bound to the DNA template, but not
the free chromium, which produces increased poly-
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merase processivity. The results shown here pertain to
DNA polymerase 3, but similar results have been seen
with DNA polymerase oc (20) and E. coli polymerase I
(20; Snow et al., unpublished observations).
In our previous study, when M13mp2 double-stranded
DNA was treated with CrCl3 (0.5 mM) and transfected
into E. coli, the mutation frequency increased only 2-
fold above the control (20). More positive results have
since been obtained with M13mp2 single-stranded phage.
This mutagenesis assay, in contrast to the oX174 rever-
sion assay, can detect a wide variety ofmutations within
the regulatory and coding sequences ofthe lacZa gene.
When primed single-stranded, M13mp2 DNA templates
were pretreated with 1 to 10 ,uM CrCl3 and separated
from unbound Crttt ions by Sephadex G-50 gel filtration
prior to transfection into competent JM101 cells, the
mutation frequency is increased in a dose-dependent
manner up to 5-fold above background (Table 1). The
concurrent decrease in phage recovery is indicative of
CrCl3 toxicity at concentrations as low as 1 ,uM. Consis-
tent with reports from other laboratories (2), we have
also observed that the CrCl1 can also induce dose-
dependent DNA-DNA crosslinking (20). Such crosslinks
are expected to stop DNA replication (28,29) and may
correlate with the toxicity of CrCl3 in the mutagenesis
assay with E. coli. The toxicity of Crtt' in the present
study was similar to that reported by Schaaper et al.
(23). Since DNA-protein crosslinking is also mediated
by Crtt' in vitro (26) it might be involved in the inhibi-
tion of DNA replication observed at higher concentra-
tions ofchromium (20).
These observations of CrI"'-mediated increases in
polymerase processivity and mutagenesis are very
similar to the effects seen with low (micromolar) con-
centrations of manganese (MnCl2). Magnesium ions are
usually required as cofactors for DNA polymerase ac-
tivity. However, MnCl2 has been shown to substitute
for MgCl2 during DNA replication in vitro (30). At low
concentrations, manganese binds preferentially to the
phosphate backbone of the DNA template (31,32) and,
like chromium, both increases DNA polymerase pro-
cessivity (33) and decreases fidelity (32,34). Manganese
has been shown to be mutagenic in vitro (8,15) and in
vivo (35) and can increase polymerase-mediated nucle-
otide insertion opposite DNA lesions (36). Manganese
also increases the production of nontargeted base sub-
stitutions and frameshift mutations (37) and nonspecific
initiation of RNA transcription (38). Cr11' has likewise
been shown to increase nonspecific initiation by RNA
polymerase in vitro (17-19) and in vivo (18) and may act
by a similar mechanism.
The increased binding of DNA polymerases to DNA
templates by Cr"' or Mn" may specifically increase
bypass across DNA-damage or noncoding lesions. Poly-
merase infidelity during DNA replication past the
oxidative damage sites potentially produced during the
intracellular reduction of chromium could partially
account for the high mutagenic and carcinogenic poten-
tial of chromate in vivo. A model for CrI'-mediated
mutagenesis is shown in Figure 4. Under normal condi-
tions, a replicative DNA polymerase encounters a DNA
lesion, pauses, and allows time for DNA repair enzymes
to recognize and remove the lesion. The polymerase
then continues accurate replication of the template. In
the presence of small amounts of Cr"', however, the
polymerase is more tightly bound to the template, and
either may not stop at a DNA lesion or may pause too
briefly to allow proper recognition ofthe lesion by DNA
repair enzymes. The polymerase may also bind more
tightly to the nucleotide precursors, which could pro-
mote direct misincorporation. DNA polymerase I in the
presence of manganese, for example exhibits lower Km
values for both correct and incorrect nucleotide precur-
sors and shows decreased selectivity for the correct
base pair (39,40; E. T. Snow, unpublished observations).
An increased probability that polymerase will insert an
incorrect base opposite a DNA lesion will facilitate by-
Polymerase Processivity& Mutagenesis
1) Polymerase Pauses at Sites of Damage
5'
3'
2) Allows Time for DNA Repair
3) And Accurate Completion of Synthesis
In the Presence of Cr3+
1) Polymerase Binds More Tightly
5'
3'
2) Bypasses Damage and Misinserts
3) Producing Mutations in the DNA
Table 1. Mutagenesis ofCrCl3-treated M13 DNA inE. coli.a
CrC13, Survival, Mutant plaques/ Mutation
PM So total plaques frequency, x 10'
0 100 2/22,495 9
1 82.4 16/48,928 33
5 37.8 10/22,403 45
10 18.1 5/10,796 46
aMutagenesis of the lacZ gene in M13mp2 was determined after
transfection of chromium-treated phage DNA into E. coli JM101, as
describedin"ExperimentalProcedures."Survivalwasmeasuredasthe
total number ofplaques per nanogram oftransfected DNA relative to
the untreated control (400 plaques/ng).
FIGURE 4. A model for Cr"'-mediated mutagenesis by polymerase by-
pass. As shown on the left, 1) a replicative DNA polymerase is
expected to pause at sites ofDNA damage, which will 2) allow time
for DNA repair enzymes to recognize and remove the DNA lesion
and3) promote the subsequent accurate completion ofDNAreplica-
tion. However, in the presence ofCr"l, as shown on the right, 1) the
DNA polymerase is more tightly bound to the template, making it
more processive and also less faithful. Under these circumstances,
when the polymerase encounters a lesion, it is less likely to pause or
fall off the template and does not allow recognition of the lesion.
Instead, 2) the polymerase is more likely to bypass the lesion and
insert an incorrect base opposite the damaged or miscoding base.
This could result3)intheproductionofamutationoppositethelesion
and, consequently, could also lead to increased tumorigenesis.
5'
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pass of the damage site, producing a mutation in the
process. Alternatively, Criii, also like manganese (31), is
known to bind preferentially to guanine-containing DNA
(41,42). This may result in direct mispairing or may
promote oxidation (7) or depurination (23) of the gua-
nine, causing subsequent mispairing of the modified
(or missing) base.
The exact mechanisms ofCr'II mutagenesis and CrIII-
mediated crosslinking orproduction ofoxidative damage
in vivo are still far from clear; however, the effects of
Cr"', which are shown here to occur at extremely low
concentrations, could be significant at the low doses of
chromium that are characteristic of environmental ex-
posures to chromate or after limited cellular uptake of
environmentally plentiful Crl1'.
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